These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15739619)

  • 1. Current status of anti-SARS agents.
    Shigeta S; Yamase T
    Antivir Chem Chemother; 2005; 16(1):23-31. PubMed ID: 15739619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS coronavirus anti-infectives.
    Tong TR
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):297-308. PubMed ID: 18221155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta 1a and SARS coronavirus replication.
    Hensley LE; Fritz LE; Jahrling PB; Karp CL; Huggins JW; Geisbert TW
    Emerg Infect Dis; 2004 Feb; 10(2):317-9. PubMed ID: 15030704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
    Tong TR
    Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronaviruses and their therapy.
    Haagmans BL; Osterhaus AD
    Antiviral Res; 2006 Sep; 71(2-3):397-403. PubMed ID: 16837072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-SARS coronavirus agents: a patent review (2008 - present).
    Kumar V; Jung YS; Liang PH
    Expert Opin Ther Pat; 2013 Oct; 23(10):1337-48. PubMed ID: 23905913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent patents on treatment of severe acute respiratory syndrome (SARS).
    Zhai S; Liu W; Yan B
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):1-10. PubMed ID: 18221160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiretroviral drugs in severe acute respiratory syndrome].
    Yazdanpanah Y; Guéry B
    Presse Med; 2006 Jan; 35(1 Pt 2):105-7. PubMed ID: 16462674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
    Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of SARS with human interferons.
    Antonelli G; Scagnolari C; Vicenzi E; Clementi M
    Lancet; 2003 Oct; 362(9390):1158; author reply 1158-9. PubMed ID: 14550714
    [No Abstract]   [Full Text] [Related]  

  • 13. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
    Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious diseases. Deferring competition, global net closes in on SARS.
    Enserink M; Vogel G
    Science; 2003 Apr; 300(5617):224-5. PubMed ID: 12690153
    [No Abstract]   [Full Text] [Related]  

  • 15. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.
    Yamamoto N; Yang R; Yoshinaka Y; Amari S; Nakano T; Cinatl J; Rabenau H; Doerr HW; Hunsmann G; Otaka A; Tamamura H; Fujii N; Yamamoto N
    Biochem Biophys Res Commun; 2004 Jun; 318(3):719-25. PubMed ID: 15144898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
    Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
    Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
    Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
    Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicases as antiviral drug targets.
    Huang JD; Zheng BJ; Sun HZ
    Hong Kong Med J; 2008 Aug; 14 Suppl 4():36-8. PubMed ID: 18708673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.